In our study, higher IL-13 values were found in MetS patients in comparison to the healthy group, and the observations were similar to the outcomes reported by Martínez-Reyes et al.43, where higher IL-13 values were observed in the insulin resistance group. This evidence concerns the gene IL13 and metabolic syndrome.